Anti-Tumour Activity of the Fluorescent Dye, Acridine Orange, on Yoshida Sarcoma (Ascites)
1963
Anti-Tumour Activity of Acridine Orange on Yoshida Sarcoma
Sample size: 24
publication
Evidence: moderate
Author Information
Author(s): K. S. Korgaonkar, Jayashree V. Sukhatankar
Primary Institution: Indian Cancer Research Centre
Hypothesis
Can acridine orange selectively target and suppress malignant cells in Yoshida sarcoma?
Conclusion
Acridine orange injections can significantly suppress ascites fluid formation and improve survival in rats with Yoshida sarcoma.
Supporting Evidence
- Animals receiving acridine orange showed a gradual rise in body weight and suppression of fluid formation.
- Control animals showed rapid weight gain and fluid formation, with a survival time of only 4-5 days.
- All experimental animals survived the observation period of 3 to 8 months when treated with acridine orange.
Takeaway
A special dye called acridine orange can help sick rats with a type of cancer feel better and live longer.
Methodology
Wistar male rats were injected with acridine orange at various doses after receiving ascites fluid, and their body weights and survival times were monitored.
Limitations
The study was limited to a specific type of cancer in a small animal model.
Participant Demographics
Two months old Wistar male rats.
Want to read the original?
Access the complete publication on the publisher's website